Updated Jul 16, 2026
Modig Berndt has filed 5 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $931K.
Berndt Modig is associated with Pharvaris N.V., a biopharmaceutical company focused on developing treatments for hereditary angioedema. Specific details about his role or contributions to the company are not widely documented.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-15 | PHVS | Pharvaris N.V. | S — Open-market sale [10b5-1] | 2.3K | $34.97 | $80K |
| 2026-06-17 | PHVS | Pharvaris N.V. | S — Open-market sale | 100 | $31.46 | $3K |
| 2026-06-17 | PHVS | Pharvaris N.V. | S — Open-market sale | 2.2K | $31.05 | $68K |
| 2026-05-20 | PHVS | Pharvaris N.V. | S — Open-market sale | 2.3K | $29.22 | $67K |
| 2026-04-20 | PHVS | Pharvaris N.V. | S — Open-market sale | 2.3K | $28.60 | $66K |
| 2026-04-10 | PHVS | Pharvaris N.V. | S — Open-market sale [10b5-1] | 200 | $28.41 | $6K |
| 2026-04-10 | PHVS | Pharvaris N.V. | S — Open-market sale [10b5-1] | 23.1K | $27.74 | $642K |
Berndt Modig is associated with Pharvaris N.V., a biopharmaceutical company focused on developing treatments for hereditary angioedema. Specific details about his role or contributions to the company are not widely documented.…
5 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 7 open-market sales ($931K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Modig Berndt profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.